Fresenius Medical Care AG & Co. KGaA / Final Results 24.02.2010 06:58 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Fresenius Medical Care Reports Full Year 2009 Results Net revenue of Fresenius Medical Care AG & Co. KGaA was $11,247 million in 2009, up 6% compared to 2008. At constant currency, net revenue rose by 9%. Operating income (EBIT) increased by 5% to $1,756 million. For the full year 2009, net income attributable to Fresenius Medical Care AG & Co. KGaA was $891 million, up 9% from 2008. For the thirteenth consecutive year, shareholders can expect to receive an increased annual dividend. At the Annual General Meeting to be held on May 11, 2010, shareholders will be asked to approve a dividend per ordinary share of EUR0.61, an increase of 5% (2008: EURO 0.58). For the full year 2010, the Company expects to achieve revenue of more than $12 billion. Net income attributable to Fresenius Medical Care AG & Co. KGaA is expected to be between $950 million and $980 million in 2010. The Company expects to spend $550 to $650 million on capital expenditures and up to $400 million on acquisitions. Fresenius SE (WKN 578560, 578563) holds approximately 36% of Fresenius Medical Care AG & Co. KGaA's capital. Fresenius Medical Care AG & Co. KGaA, Represented by Fresenius Medical Care Management AG, Board of Management, Bad Homburg v.d.H., February 24, 2010 24.02.2010 06:58 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Medienarchiv at |[![CDATA[|[a href="http://www.dgap-medientreff.de"|]www.dgap-medientreff.de|[/a|]]]|] and |[![CDATA[|[a href="http://www.dgap.de"|]www.dgap.de|[/a|]]]|] --------------------------------------------------------------------------- Language: English Company: Fresenius Medical Care AG & Co. KGaA Else-Kröner-StraÃe 1 61352 Bad Homburg Deutschland Phone: +49 (0) 6172- 609 2525 Fax: +49 (0) 6172- 609 2301 E-mail: ir@fmc-ag.com Internet: www.fmc-ag.de ISIN: DE0005785802, DE0005785836, WKN: 578580, 578583 Indices: DAX Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, München, Hannover, Düsseldorf, Hamburg, Stuttgart; Terminbörse EUREX; Foreign Exchange(s) NYSE End of News DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA: Reports Full Year 2009 Results
| Source: EQS Group AG